Italy· 026057012
CARTEOL*collirio 5 ml 10 mg/ml
A medicinal product containing carteololo, registered in Italy by SIFI SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Carteololo
- Manufacturer
- SIFI SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic026057012CARTEOL*collirio 5 ml 10 mg/mlEUR 4.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carteololo in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsLexon (UK) Ltd
- Japanカルテオロール塩酸塩大塚製薬
- BelgiumArteoptic LA 1 %Bausch & Lomb Pharma
- FranceCARTEOL 1 %, collyre en solutionLABORATOIRE CHAUVIN
- SpainARTEOPTIC 1% COLIRIO DE LIBERACION PROLONGADABausch + Lomb Ireland Limited
- PolandCarteol LP 2%Medezin Sp. z o.o.
- SwitzerlandArteoptic LA
- NetherlandsArteoptic zonder conserveermiddel 20 mg/ml, oogdruppels, oplossing met verlengde afgifteBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Arteoptic La, Arteoptic La Sine Conservans
- Czechia · Carteol Lp, Carteol Neo
- Spain · Arteoptic, Arteoptic Pf
- France · Carteol, Carteol L.P.
- Croatia · Cartelomb
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b779680b-7447-4532-929c-39e938b2322e GET /v1/drugs/b779680b-7447-4532-929c-39e938b2322e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4.8,
"source": "aifa",
"currency": "EUR",
"strength": "CARTEOLOLO 1% 5ML SOLUZIONE USO OFTALMICO",
"substance": "Carteololo",
"equivalence_group": "ITD",
"transparency_flag": null
}See everything about carteololo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.